Global Nuclear Medicine Market Opportunities & Forecast to 2023: Expected to Show a Robust Growth of 10.07% CAGR – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global
Nuclear Medicine Market: Analysis By Product Type, By Diagnostic Nuclear
Medicine Type, By Therapeutic Nuclear Medicine Type, By Indication, By
Region, By Country (2019 Edition): Opportunities and Forecast
(2013-2023)”
report has been added to ResearchAndMarkets.com’s
offering.

A comprehensive research report created through extensive primary
research (inputs from industry experts, companies, stakeholders) and
secondary research, the report aims to present the analysis of Global
Nuclear Medicine Market.

The report analyzes the Nuclear Medicine Market By Product (Therapeutic,
Diagnostic), By Diagnostics (SPECT, PET), By Therapeutics (Alpha
Emitters, Beta Emitters, Brachytherapy) and By Indication
(Cardiovascular Disorders, Oncological Disorders, Neurological
Disorders, Others).

The Nuclear Medicine Market has been analyzed By Region (North America,
Europe, Asia Pacific, Rest of the World) and By Country (U.S., Canada,
France, Germany, India, China, Japan and Brazil) for the historical
period of 2013-2017 and the forecast period of 2018-2023.

According to the report, the global market is projected to display a
robust growth represented by a CAGR of 10.07% during
2018-2023.

The indication segment of Oncological disorders has been witnessing
growth at a noteworthy rate over the past few years backed by increased
prevalence of cancer, presence of technical advance PET and SPECT
equipment to perform treatment, rising number of nuclear centers.

Amongst the regions, North America accounts for the largest regional
share in the global nuclear medicine market in 2018. Key factors driving
the robust growth rate of North America region include well developed
healthcare infrastructure, favorable regulatory reforms, rising
prevalence of chronic ailment such as cardiovascular disorders,
neurological disorders etc. in the region.

Topics Covered

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Nuclear Medicine Market Overview

5. Global Nuclear Medicine: Growth and Forecast

5.1 By Value (2013-2017)
5.2 By Value (2018-2023)

6. Global Nuclear Medicine Market: By Indication
6.1 Global Nuclear
Medicine Market-By Product Type: Breakdown(%)
6.2 Global Diagnostic
Nuclear Medicine Market Overview
6.3 Global Therapeutic Nuclear
Medicine Market Overview

7. Global Nuclear Medicine Market: By Therapeutic Type
7.1 Global
Nuclear Medicine Market: By Therapeutic Type: Breakdown(%)
7.2
Global Beta Emitters Nuclear Medicine Market Overview
7.3 Global
Alpha Emitters Nuclear Medicine Market Overview
7.4 Global
Brachytherapy Nuclear Medicine Market Overview

8. Global Nuclear Medicine Market:By Diagnostic Type
8.1 Global
Nuclear Medicine Market:By Diagnostic Type: Breakdown(%)
8.2 Global
SPECT Nuclear Medicine Market Overview
8.3 Global PET Nuclear
Medicine Market Overview

9. Global Nuclear Medicine Market:By Indication
9.1 Global Nuclear
Medicine Market:By Indication: Breakdown(%)
9.2 Global Nuclear
Medicine For Oncological Disorders Market
9.3 Global Nuclear
Medicine For Cardiovascular Disorders Market
9.4 Global Nuclear
Medicine For Neurological Disorders Market
9.5 Global Nuclear
Medicine For Other Disorders Market

10. Global Nuclear Medicine Market: Regional Analysis
10.1 Global
Nuclear Medicine Market, By Region: Breakdown (%)
10.2 North
America Nuclear Medicine Market: An Analysis
10.3 North America
Nuclear Medicine Market: Segment Analysis
10.4 North America
Nuclear Medicine Market: Country Analysis (U.S. and Canada)
10.5
Europe Nuclear Medicine Market: An Analysis
10.6 Europe Nuclear
Medicine Market: Segment Analysis
10.7 Europe Nuclear Medicine
Market: Country Analysis (Germany, France, Rest of Europe)
10.8
Asia Pacific Nuclear Medicine Market: An Analysis
10.9 Asia Pacific
Nuclear Medicine Market: Segment Analysis
10.10 Asia Pacific
Nuclear Medicine Market: Country Analysis (India, China Japan & Rest of
Asia Pacific)
10.11 Rest of World Nuclear Medicine Market: An
Analysis
10.12 Rest of World Nuclear Medicine Market: Segment
Analysis
10.13 Rest of World Nuclear Medicine Market: Country
Analysis (Brazil & Others)

11. Market Dynamics
11.1 Drivers
11.2 Challenges

12. Market Trends

13. Porter’s Five Forces Analysis-Nuclear Medicine Market

14. SWOT Analysis-Nuclear Medicine Market

15. Supply Chain Analysis Nuclear Medicine Market

16. Policy and Regulatory Landscape

17. Competitive Landscape

18. Company Profiles
18.1 Eckert & Ziegler
18.2 Advanced
Accelerator Applications
18.3 Cardinal Health
18.4 3B
Pharmaceuticals
18.5 Jubilant Life Sciences
18.6 Curium
18.7
Lantheus Holdings
18.8 Bracco Imaging

For more information about this report visit https://www.researchandmarkets.com/research/5d4rvw/global_nuclear?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Diagnostics,
Nuclear
Medicine and Radiopharmacology